NIH Grants

The 2026 UMR economic impact report shows NIH funding produced $94 billion in activity and nearly 400,000 jobs — while success rates hit a 30-year low. The strongest economic argument against cutting biomedical research funding, and what researchers should do now.

The Complement-ARIE program funds organ-on-chip, computational biology, and human tissue models to replace animal research. A deep look at what it means for funding strategy.

NIH slashed active NOFOs from 800+ to under 500, shifting to investigator-initiated science. What researchers gain in freedom, they lose in clarity.

NIH awarded 5,564 fewer grants in FY2025 due to forward funding. At NCI, odds dropped from 1-in-10 to 1-in-25. What researchers need to know to compete in a shrinking pool.

The Complement-ARIE program funds seven technology centers to develop human-based models that complement animal research. What it means for drug developers, academic researchers, and the regulatory pipeline.

NIH has quietly stopped issuing agency-directed funding announcements, with 271 fully developed NOFOs stuck in political review. What the shift to unsolicited science means for researchers.

A new PNAS study finds women lost 57.9% of their NIH grant funding versus 48.2% for men. A companion STAT survey of 1,000 researchers reveals mass layoffs and canceled research.

NIH paylines vary by institute, career stage, and fiscal year. Learn how percentile cutoffs, select pay, and budget dynamics determine whether your R01 gets funded.

NIH reviewers score innovation differently than most applicants expect. A detailed look at what study sections reward, what they penalize, and how the criterion has evolved.

A paragraph-by-paragraph breakdown of the NIH R01 Specific Aims page, with structural guidance, reviewer psychology, and the mistakes that sink fundable science.

How to research, request, and navigate NIH study section assignment to ensure your grant lands in front of reviewers who actually understand your science.

The NIH awarded 5,564 fewer grants in FY2025 than the year before, and FY2026 looks worse. A deep analysis of forward funding, politicization, leadership gaps, and what researchers should do now.

The NIH 2027-2031 strategic plan will guide roughly $250 billion in research funding decisions. Public comment is open, and the first webinar already happened. Here is how to make your input count.

The 2026 NIH biosketch overhaul splits your record into a Common Form and a Supplement, demands SciENcv certification, and caps your scientific story at 2,000 characters per contribution. How to write it strategically.

With competitive NIH awards down 74%, success rates at 30-year lows, and OMB restricting fund releases, biomedical researchers face an unprecedented funding crisis. Strategic responses for navigating the squeeze.

With success rates plunging to 17% and multiyear funding eliminating nearly 1,000 grants in FY2026, biomedical researchers face the most competitive funding landscape in a generation.

The reclassification of federal grant-making employees under Schedule F could politicize billions in research funding decisions. Grant seekers need to understand the stakes and adapt their strategies now.

NIH will no longer fund foreign subawards on domestic grants. The new PF5 activity code creates a parallel award structure that gives NIH direct oversight of every dollar sent abroad — and researchers must adapt fast.

The administration proposed merging 27 NIH institutes into 8. Congress rejected every version. But administrative actions are dismantling the agency from within — and researchers need to understand what is changing.

NIH success rates are plummeting and multiyear funding is consuming competing awards. The strategic choice between R01 and R21 mechanisms has never mattered more — or been less straightforward.

NIH is investing $130 million over four years to turn biomedical datasets into AI-ready infrastructure. Here is what Stage 2 funds, who should apply, and why the program matters more than its budget suggests.

The NIH has ended decades of transparent score-based funding cutoffs in favor of subjective criteria including geography and career stage. For researchers, the implications are enormous.

New data reveals AI-drafted grant proposals have higher NIH success rates but lower novelty scores. Combined with the six-application annual cap and AI ban, the landscape for researchers is shifting fast.

NIH R01 success rates dropped from 29.8% to 18.5%. Here are 5 tactics to write a proposal that still wins in 2026 when the payline has fallen.

NIH now limits PIs to six grant submissions annually and bans AI-generated proposals. What researchers need to know about the biggest NIH policy shift in a decade.

After court settlements with state attorneys general and the ACLU, NIH is re-reviewing more than 5,000 previously frozen or denied grant applications. What happened, who is affected, and what to do next.

Despite NIH budget pressure, hundreds of millions in AI healthcare research grants remain active in 2026. Full breakdown of Bridge2AI, AHRQ patient safety, NSF/NIH Smart Health, BARDA, Gates Foundation, and Google.org — with eligibility, amounts, and current deadlines.

NIH funded $2.3 billion in AI and ML research in FY2023 alone. Here is how researchers and institutions can find and apply to the growing pool of AI-tagged NIH FOAs.

California, Massachusetts, New York, Pennsylvania, and Texas are launching billions in state-funded research grants as federal success rates hit historic lows. Here is where the new money is.

We tested 7 AI grant writing tools on real NIH, NSF & SBIR proposals. 2026 rankings with actual proposal scores — see which tools work.

A deep dive into how AI-powered review panels can simulate the NIH study section process -- independent scoring, deliberation, and consensus -- to strengthen grant proposals before submission.

Insider tips from NIH reviewers on what they prioritize in grant proposals. Specific Aims, preliminary data, and pitfalls to avoid.

Why most NIH R01 proposals fail and how to fix common mistakes. Avoid unclear aims, weak methodology, and insufficient preliminary data.

Craft an NIH Biosketch that proves you are the right PI. Tips on personal statements, contributions to science, and research support.

Master the NIH resubmission process. Analyze Summary Statements, address reviewer critiques, and revise your grant proposal for funding success.

How does NIH's 1-to-9 scoring work? Learn what impact scores, percentiles, and study section reviews mean for your grant's funding chances.

Comprehensive NIH K award guide covering K01, K08, K23, K99/R00, eligibility, mentorship plans, effort requirements, and choosing the right mechanism.

NIH grant writing tips for new investigators. How to pick the right mechanism (R01, K08, K23), find FOAs, build preliminary data, and write a fundable first application.

The complete NIH grant writing guide covering R01, R21, K awards, study sections, review criteria, Specific Aims, budgets, biosketches, and resubmission.

Master NIH grant writing fundamentals: structure your Specific Aims page, demonstrate significance and innovation, and build a winning proposal.

Step-by-step guide to the NIH F31 predoctoral fellowship covering eligibility, specific aims, training plans, sponsor selection, and scoring criteria.

Decode NIH funding mechanisms including R01, K08, and F31 series grants to find the right award type for your research career stage and goals.

Maximize your NIH grant impact by aligning your research proposal with public health priorities, strategic plans, and institute-specific objectives.

The Significance section is where most NIH proposals lose points. See what study sections actually look for and examples of high-scoring pages.

Avoid common NIH grant proposal mistakes including vague specific aims, weak methodology, and poor budget justification that lead to rejection.

Learn how to write a rigorous NIH Research Strategy Approach section with practical tips for specific aims, methodology, and reviewer persuasion.